At the news
? NEUTRALIMPACT 2/10 6-K filed Aug 11, 2026 at 14:14 ET
Genmab filed a 6-K reporting a routine capital increase of 24,592 shares from employee warrant exercises, raising approximately DKK 37.9 million (0.04% of share capital). This is a standard administrative event with no material impact on the company's financial position or operations.
- Share capital increased by 24,592 shares due to employee warrant exercises.
- Proceeds to the company are approximately DKK 37.9 million.
- The increase represents approximately 0.04% of Genmab's total share capital.
- Total share capital post-increase is DKK 62,377,844 (62,377,844 shares).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access